271: Racing for gene therapy, a pioneering approval, & startups in the lurch
The Readout Loud
00:00
First FDA Approved Medicine for Rare Bone Disease
This chapter discusses the significance of the FDA's approval of the first medicine for a rare bone disease called FOP. Despite not meeting its primary endpoint in clinical trials, the drug shows some effectiveness in reducing new bone formation and is seen as a milestone for patients with FOP.
Transcript
Play full episode
